X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8703) 8703
Publication (599) 599
Newsletter (565) 565
Book Review (74) 74
Newspaper Article (42) 42
Book Chapter (34) 34
Magazine Article (12) 12
Conference Proceeding (10) 10
Dissertation (6) 6
Trade Publication Article (6) 6
Data Set (3) 3
Book / eBook (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6107) 6107
tacrolimus (5356) 5356
male (4508) 4508
female (3921) 3921
index medicus (3585) 3585
tacrolimus - administration & dosage (3584) 3584
transplantation (3239) 3239
immunosuppressive agents - administration & dosage (3172) 3172
adult (2891) 2891
middle aged (2719) 2719
tacrolimus - therapeutic use (2312) 2312
immunosuppressive agents - therapeutic use (2238) 2238
surgery (1904) 1904
animals (1877) 1877
immunology (1647) 1647
treatment outcome (1622) 1622
cyclosporine (1539) 1539
immunosuppressive agents - adverse effects (1312) 1312
pharmacology & pharmacy (1276) 1276
tacrolimus - adverse effects (1263) 1263
aged (1260) 1260
kidney transplantation (1124) 1124
adolescent (1090) 1090
dermatology (1043) 1043
drug therapy, combination (1028) 1028
immunosuppression (990) 990
immunosuppressive agents - pharmacokinetics (961) 961
rats (940) 940
child (937) 937
tacrolimus - pharmacokinetics (914) 914
fk506 (913) 913
administration, topical (909) 909
graft rejection - prevention & control (901) 901
calcineurin inhibitors (883) 883
time factors (864) 864
research (854) 854
tacrolimus - pharmacology (845) 845
pharmacokinetics (825) 825
kidneys (812) 812
recipients (794) 794
dosage and administration (775) 775
dose-response relationship, drug (770) 770
mycophenolic acid - analogs & derivatives (748) 748
retrospective studies (748) 748
drug administration schedule (735) 735
cyclosporine - administration & dosage (685) 685
analysis (676) 676
follow-up studies (670) 670
immunosuppressive agents - pharmacology (640) 640
liver transplantation (617) 617
risk factors (617) 617
therapy (611) 611
young adult (609) 609
health aspects (590) 590
tacrolimus - blood (587) 587
liver (580) 580
administration, oral (573) 573
cyclosporine-a (573) 573
drug therapy (572) 572
mycophenolic acid - administration & dosage (571) 571
immunosuppressive agents (565) 565
prospective studies (561) 561
fk-506 (556) 556
mice (555) 555
child, preschool (554) 554
cyclosporine - therapeutic use (546) 546
organ transplant recipients (536) 536
immunosuppressive agents - blood (530) 530
tacrolimus - analogs & derivatives (529) 529
care and treatment (524) 524
children (518) 518
efficacy (514) 514
dermatitis, atopic - drug therapy (482) 482
kidney transplantation - immunology (475) 475
corticosteroids (446) 446
transplants & implants (444) 444
mycophenolate-mofetil (441) 441
mycophenolate mofetil (440) 440
immunotherapy (429) 429
graft survival - drug effects (419) 419
rejection (415) 415
kidney-transplantation (414) 414
renal-transplantation (412) 412
atopic dermatitis (411) 411
transplantation, homologous (410) 410
mycophenolic acid - therapeutic use (409) 409
medicine & public health (402) 402
medical research (394) 394
ointments (393) 393
sirolimus (389) 389
administration, cutaneous (388) 388
pediatrics (386) 386
complications and side effects (384) 384
transplantation of organs, tissues, etc (373) 373
graft survival (370) 370
safety (369) 369
urology & nephrology (368) 368
drug interactions (365) 365
graft rejection (360) 360
medicine, experimental (356) 356
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8958) 8958
Japanese (130) 130
German (90) 90
French (55) 55
Spanish (41) 41
Chinese (36) 36
Korean (10) 10
Polish (8) 8
Portuguese (8) 8
Hungarian (4) 4
Italian (4) 4
Russian (4) 4
Finnish (3) 3
Danish (2) 2
Croatian (1) 1
Czech (1) 1
Dutch (1) 1
Hebrew (1) 1
Norwegian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2007, Volume 357, Issue 25, pp. 2562 - 2575
This study examines the toxicity of immunosuppressive regimens in renal-transplant recipients. A regimen containing mycophenolate mofetil, daclizumab, low-dose... 
MULTICENTER TRIAL | MEDICINE, GENERAL & INTERNAL | CYCLOSPORINE MICROEMULSION | EFFICACY | KIDNEY-TRANSPLANTATION | IMMUNOSUPPRESSION | ALLOGRAFT RECIPIENTS | TACROLIMUS | MYCOPHENOLATE-MOFETIL | SIROLIMUS | NEPHROTOXICITY | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Adrenal Cortex Hormones - therapeutic use | Enzyme Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized | Calcineurin Inhibitors | Treatment Failure | Adult | Diabetes Mellitus - etiology | Female | Drug Therapy, Combination | Mycophenolic Acid - administration & dosage | Immunosuppressive Agents - administration & dosage | Sirolimus - adverse effects | Tacrolimus - administration & dosage | Prednisone - administration & dosage | Glomerular Filtration Rate | Graft Rejection - prevention & control | Kaplan-Meier Estimate | Kidney Transplantation | Immunoglobulin G - administration & dosage | Opportunistic Infections | Sirolimus - administration & dosage | Mycophenolic Acid - analogs & derivatives | Antibodies, Monoclonal - administration & dosage | Cyclosporine - administration & dosage | Immunosuppressive Agents - adverse effects | Aged | Adrenal Cortex Hormones - administration & dosage | Transplantation | Corticosteroids | Kidneys | Research | Health aspects | Immunosuppressive agents | Medical research | Immunology | Inhibitor drugs | Transplants & implants | Toxicity | Inhibidors enzimàtics | Posologia | Ús terapèutic | Corticosteroides | Rebuig (Biologia) | Posology | Therapeutic use | Immunosupressive agents | Graft rejection | Trasplantament renal | Enzyme inhibitors | Adrenocortical hormones | Immunosupressors | Kidney transplantation | Tacrolimus: administration & dosage | Medical and Health Sciences | Graft Rejection: prevention & control | Immunoglobulin G: administration & dosage | Medicin och hälsovetenskap | Mycophenolic Acid: administration & dosage | Antibodies | Klinisk medicin | Monoclonal: administration & dosage | Prednisone: administration & dosage | Adrenal Cortex Hormones: administration & dosage | Immunosuppressive Agents: administration & dosage | Mycophenolic Acid: analogs & derivatives | Sirolimus: administration & dosage | Cyclosporine: administration & dosage | Calcineurin: antagonists & inhibitors | Diabetes Mellitus: etiology | Urologi och njurmedicin | Sirolimus: adverse effects | Adrenal Cortex Hormones: therapeutic use | Enzyme Inhibitors: administration & dosage | Immunosuppressive Agents: adverse effects | Clinical Medicine | Immunosuppressive Agents: therapeutic use | Urology and Nephrology
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 08/2012, Volume 161, Issue 3, pp. 735 - 745
The objective of the present study was to investigate the effect of polyarginine chain length on topical delivery of surface modified NLCs. Design of... 
Nanostructured lipid carriers (NLC) | Cell penetrating peptide (CPP) | Polyarginine peptide | Skin delivery | Allergic contact dermatitis (ACD) | DRUG-DELIVERY | CHITOSAN CROSS-LINKING | TRANSDERMAL DELIVERY | MEFLOQUINE HYDROCHLORIDE MICROPARTICLES | CELL-PENETRATING PEPTIDES | TACROLIMUS OINTMENT | CHEMISTRY, MULTIDISCIPLINARY | DERMAL DELIVERY | PHARMACOLOGY & PHARMACY | H-II MESOPHASES | SUBSTANCE-P | SPANTIDE-II | Nanoparticles - chemistry | Drug Carriers - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Male | Drug Carriers - chemistry | Peptides - administration & dosage | Ketoprofen - chemistry | Allergens - administration & dosage | Lipids - chemistry | Rats, Hairless | Skin Absorption - drug effects | Substance P - analogs & derivatives | Oligopeptides - chemistry | Cell-Penetrating Peptides - chemistry | Dermatitis, Allergic Contact - drug therapy | Peptides - chemistry | Mice, Inbred C57BL | Ketoprofen - administration & dosage | Rats | Lipids - administration & dosage | Dinitrofluorobenzene - administration & dosage | Animals | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Mice | Nanoparticles - administration & dosage | Oligopeptides - administration & dosage | Cell-Penetrating Peptides - administration & dosage | Administration, Topical | Substance P - chemistry | Substance P - administration & dosage | Usage | Peptides | Dermatology | Analysis | Formulae, receipts, prescriptions | Dermatologic agents | Skin | Raman spectroscopy | Transdermal medication | polyarginine peptide | cell penetrating peptide (CPP) | nanostructured lipid carriers (NLC) | allergic contact dermatitis (ACD)
Journal Article
Journal Article
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 05/2015, Volume 15, Issue 5, pp. 1313 - 1322
The authors describe the drug–drug interaction profile of the he patitis C direct‐acting antiviral agents ABT‐450, ombitasvir, and dasabuvir with cyclosporine... 
infectious disease | clinical research/practice | pharmacology | calcineurin inhibitor: cyclosporine A (CsA) | pharmacokinetics/pharmacodynamics | immunosuppressant | infection and infectious agents | calcineurin inhibitor: tacrolimus | liver transplantation/hepatology | viral: hepatitis C | SURGERY | ABT-450/R-OMBITASVIR | LIVER-TRANSPLANTATION | EFFICACY | DRUG-INTERACTIONS | TRANSPORTERS | INFECTION | HCV | RIBAVIRIN | INHIBITOR | HEPATITIS-C | TRANSPLANTATION | Antiviral Agents - pharmacokinetics | Hepatitis C - drug therapy | Area Under Curve | Humans | Middle Aged | Male | Anilides - pharmacokinetics | Carbamates - administration & dosage | Healthy Volunteers | Carbamates - pharmacokinetics | Young Adult | Uracil - administration & dosage | Cyclosporine - pharmacokinetics | Adult | Female | Tacrolimus - administration & dosage | Hepacivirus - drug effects | Drug Administration Schedule | Macrocyclic Compounds - pharmacokinetics | Tacrolimus - pharmacokinetics | Antiviral Agents - administration & dosage | Sulfonamides - pharmacokinetics | Anilides - administration & dosage | Adolescent | Cyclosporine - administration & dosage | Macrocyclic Compounds - administration & dosage | Uracil - pharmacokinetics | Sulfonamides - administration & dosage | Uracil - analogs & derivatives | Dosage and administration | Liver diseases | Drug therapy, Combination | Tacrolimus | Hepatitis C virus | Hepatitis C | Hepatitis | Medical research | Drug dosages | practice | pharmacodynamics | hepatology | clinical research | pharmacokinetics | Original | liver transplantation
Journal Article
Circulation, ISSN 0009-7322, 12/2004, Volume 110, Issue 25, pp. 3858 - 3865
Drugs | Rejection | Transplantation | Immune system | CARDIAC & CARDIOVASCULAR SYSTEMS | MYCOPHENOLATE MOFETIL RS-61443 | CYCLOSPORINE MICROEMULSION | TACROLIMUS FK506 | drugs | COMBINATION THERAPY | RANDOMIZED MULTICENTER | RENAL-TRANSPLANTATION | rejection | CLINICAL-EXPERIENCE | RAPAMYCIN AY-22,989 | transplantation | immune system | PERIPHERAL VASCULAR DISEASE | CARDIAC ALLOGRAFT-REJECTION | LIVER-TRANSPLANT | Azathioprine - administration & dosage | Azathioprine - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Adrenal Cortex Hormones - therapeutic use | Antimetabolites - therapeutic use | Mycophenolic Acid - pharmacology | Everolimus | Sirolimus - adverse effects | Antimetabolites - pharmacology | Tacrolimus - administration & dosage | Transplantation, Homologous - adverse effects | Graft Rejection - drug therapy | Heart Transplantation - immunology | Administration, Oral | Adrenal Cortex Hormones - pharmacology | Heart Transplantation - adverse effects | Adrenal Cortex Hormones - adverse effects | Antimetabolites - adverse effects | Cyclosporine - therapeutic use | Protein Kinase Inhibitors - administration & dosage | Growth Inhibitors - administration & dosage | Mycophenolic Acid - analogs & derivatives | Cyclosporine - adverse effects | Cyclosporine - administration & dosage | TOR Serine-Threonine Kinases | Cyclosporine - pharmacology | Calcineurin Inhibitors | Tacrolimus - pharmacology | Mycophenolic Acid - administration & dosage | Growth Inhibitors - pharmacology | Immunosuppressive Agents - pharmacology | Immunosuppressive Agents - administration & dosage | Protein Kinases - drug effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Graft Rejection - prevention & control | Azathioprine - pharmacology | Clinical Trials as Topic | Tacrolimus - adverse effects | Sirolimus - pharmacology | Transplantation, Homologous - immunology | Antimetabolites - administration & dosage | Growth Inhibitors - therapeutic use | Mycophenolic Acid - adverse effects | Sirolimus - administration & dosage | Tacrolimus - therapeutic use | Mycophenolic Acid - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Immunosuppressive Agents - adverse effects | Protein Kinase Inhibitors - pharmacology | Growth Inhibitors - adverse effects | Azathioprine - adverse effects | Adrenal Cortex Hormones - administration & dosage
Journal Article
Journal Article
Journal Article
Transplantation, ISSN 0041-1337, 12/2005, Volume 80, Issue 12, pp. 1734 - 1741
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 05/2019, Volume 562, pp. 1 - 10
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2008, Volume 14, Issue 6, pp. 641 - 650
Abstract We evaluated the safety and efficacy of high-dose, posttransplantation cyclophosphamide (Cy) to prevent graft rejection and graft-versus-host disease... 
Hematology, Oncology and Palliative Medicine | Bone marrow transplantation | Cyclophosphamide | Histocompatibility antigens | Conditioning regimens | Lymphoma | Leukemia | TOTAL-BODY IRRADIATION | leukemia | IMMUNE RECONSTITUTION | lymphoma | UNRELATED DONORS | ACUTE MYELOID-LEUKEMIA | IMMUNOLOGY | VERSUS-HOST-DISEASE | bone marrow transplantation | TRANSPLANTATION | histocompatibility antigens | CORD BLOOD TRANSPLANTATION | DRUG-INDUCED TOLERANCE | IDENTICAL SIBLINGS | cyclophosphamide | STEM-CELL TRANSPLANTATION | HEMATOLOGY | MYCOPHENOLATE-MOFETIL | conditioning regimens | Whole-Body Irradiation | Cyclophosphamide - administration & dosage | Graft vs Host Disease - epidemiology | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Recombinant Proteins | Bone Marrow Transplantation - methods | Cyclophosphamide - therapeutic use | Filgrastim | Transplantation, Homologous | Bone Marrow Transplantation - immunology | Adult | Female | Transplantation Conditioning - methods | Mycophenolic Acid - administration & dosage | Graft vs Host Disease - etiology | Immunosuppressive Agents - administration & dosage | Tacrolimus - administration & dosage | Drug Administration Schedule | Graft Survival | Postoperative Complications - epidemiology | Vidarabine - analogs & derivatives | Granulocyte Colony-Stimulating Factor - therapeutic use | Postoperative Care - methods | Blood Component Transfusion | Hematologic Neoplasms - surgery | Disease-Free Survival | Tacrolimus - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Hemoglobinuria, Paroxysmal - surgery | Cyclophosphamide - pharmacology | Graft vs Host Disease - prevention & control | Aged | Vidarabine - administration & dosage | Histocompatibility | Antimitotic agents | Evaluation | Mortality | Bone marrow | Dosage and administration | Transplantation | Antineoplastic agents | T cells | Cancer | Index Medicus
Journal Article
Journal Article